Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BMI

BMI was established in the summer of 2004 with a strong portfolio of early stage innovations transferred from Medinnova and from Oslo Research Park. Today, BMI is focusing on the development of drugs based on compounds that interfere with the signal mediator serotonin. In particular, BMI is currently in clinical phase II with GSK's 5-HT4 antagonist piboserod for the treatment of heart failure. Development of drug with blockbuster potential
BMI has signed a license and development agreement with the Glaxo Group (GlaxoSmithKline “GSK”) to develop GSK’s drug candidate Piboserod, for the treatment of heart failure. More
Public Offering
To finance further development of the company and its product pipeline, BMI is currently seeking NOK 20 millions new equity through a capital increase.


Contact Details:
Gaustadallčen 21
Oslo
N-0349
Norway
Tel:47 2295 8191
Fax:47 2260 4427
Email:ingrid@bmioslo.no
WWW:

www.bmioslo.no/




Recent Publications by BMI:

EvoRSR: an integrated system for exploring evolution of RNA structural robustness.
BACKGROUND: Robustness, maintaining a constant phenotype despite...
30th September, 2009
Beijing Institute of Radiation Medicine, Beijing, PR China. BMC Bioinformatics. 2009 Aug 13;10:249.
DOI Direct Link
Structure and function of the molecular chaperone Hsp104 from yeast.
The molecular chaperone Hsp104 plays a central role in the clearance of...
22nd September, 2009
Laboratory of Molecular Neurobiology and Neuroproteomics, Swiss Federal Biopolymers. 2009 Sep 18.
DOI Direct Link
Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Loss of function of parkin, an ubiquitin ligase, is responsible for...
15th September, 2009
Ecole Polytechnique Federale de Lausanne, Brain Mind Institute, EPFL SV Neurobiol Dis. 2009 Jul;35(1):32-41. Epub 2009 Apr 5.
DOI Direct Link
Who will assess cognitive change?
The UK National Dementia Strategy 2009 outlines the problems of cognitive...
3rd September, 2009
BMI Highfield Menopause Int. 2009 Sep;15(3):94-5.
DOI Direct Link
[Signal pathways of eryptosis-review]
Erythrocytes are devoid of nuclei and mitochondria which are the crucial...
25th August, 2009
Beijing Institute of Transfusion Medicine, Academy of Military Medical Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Aug;17(4):1097-100.

View more BMI research publications.

Press Releases on BMI:

BioPortfolio Logo
Spherix Announces Results of Annual Shareholders Meeting 19th November, 2009 Spherix Incorporated
-- Robert J. Vander Zanden, Ph.D., former Vice President, R&D, Kraft Foods International In addition, Grant Thornton LLP was ratified as the Company's independent accountants
Healthy Choices for Healthy Children Legislation Introduced to Fight Childhood Obesity in Ohio 17th November, 2009 Healthy Choices for Healthy Children Coalition
COLUMBUS, Ohio, Nov. 17 /PRNewswire/ -- A bi-partisan effort to decrease and prevent childhood obesity was introduced today in the Ohio Senate and Ohio House of Representatives, with the strong
Spherix Reports Third Quarter 2009 Earnings 16th November, 2009 Spherix Incorporated
-- Completion of the trials and filing of FDA New Drug Application (NDA) expected in 2010 -- Upcoming Trade Shows/Investor Conferences: -- 2010 OneMedForum, San
Video: Spherix Announces Positive Interim Results in Phase 3 Trial of Novel, Oral Compound for Type 2 Diabetes 16th November, 2009 Spherix Incorporated
BETHESDA, Md., Nov. 16 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services
Nine Leading Research Teams Selected to Study How Digital Games Improve Players' Health 5th November, 2009 Robert Wood Johnson Foundation's Health Games Research
Researchers seek to discover how interactive video games can be designed to improve physical activity, prevention behaviors and self-management of chronic conditions PRINCETON, N.J., Nov. 5

BioNews Results for BMI:

Study Aims To Find Fun, Effective Way To Combat Pediatric Obesity
Medical News Today:  Nov 14 2009 10:15AM Matching: bmi
Medical News: Study Aims To Find Fun, Effective Way To Combat Pediatric Obesity
BioFind:  Nov 14 2009 12:57PM Matching: bmi
American College of Allergy, Asthma & Immunology, Nov. 5-10, 2009
Modern Medicine:  Nov 14 2009 2:05AM Matching: bmi
Fat collections linked to decreased heart function
PhysOrg.com:  Nov 14 2009 10:32PM Matching: bmi
Bariatric Medical Institute of Texas Surgeons Named San Antonios Top Doctors by Scene in S.A. Magazine
Yahoo! Canada:  Nov 14 2009 12:23AM Matching: bmi
Promote your company here: BioNewsCast - Press Release Distribution

View more BMI news.

BMI Patents:

US Patent No.Title
7377059 Ironing board
4272020 Gunning apparatus for in situ spraying of refractory material
4364798 Rebuilt coke oven heating chamber and method of making the same
4478395 Refractory runner
4571318 Method of constructing refractory runner

View more BMI patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 35 individuals from BMI using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 219 times since April 2007, the link to the organisation's website has been followed 39 times

Search for more companies in Oslo

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BMI

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.